<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 3 Issue 3</issue_number>
<issue_period>2012 (July - September)</issue_period>
<title>Inducible Clindamycin Resistance Among Community And Hospital Acquired Isolates Of Staphylococcus Species </title>
<abstract>The rate of methicillin resistant Staphylococcus aureus (MRSA) infections has increased in recent years and clindamycin is considered to be one of the alternatives in these infections. In our study, a total of 337 Staphylococcus isolates from exudate samples in a tertiary care hospital were tested for inducible clindamycin resistance by D test according to the clinical laboratory standards institute (CLSI) guidelines. The inducible clindamycin resistance was higher 22% in hospital acquired MRSA isolates when compared to 9.8% in community acquired MRSA isolates. All methicillin resistant coagulase negative Staphylococci (MRCoNS) isolates were hospital acquired and they showed 20% inducible clindamycin resistance. Our study shows the increasing prevalence of inducible clindamycin resistance among Methicillin resistant Staphylococcal isolates and denotes that D test should be carried out routinely in all laboratories.</abstract>
<authors>Dr.R.Vasanthi , Dr. M.Jeya ,Mr.Karthick</authors>
<keywords>Clindamycin resistance, D test, Staphylococcus</keywords>
<pages>372-380</pages>
</article>
</Journal>
